Recherche

Image The ZELIG CenterZELIG is an outpatient service designed for young people aged 12 to 21 living in the Brussels-Capital Region, who are facing recent psychological and functional difficulties that have emerged within the past six months.The center’s mission is to identify early signs of psychological distress before they worsen. By ensuring timely access to care, ZELIG aims to prevent complications and the progression of mental health disorders.Our approach prioritizes swift responses to initial requests and thorough, systematic evaluations of each situation. We offer a tailored care pathway focused on addressing symptoms related to psychiatric conditions through early detection and relapse prevention.Feel free to reach out to us!%20%20zelig [dot] pij [at] hubruxelles [dot] be (Envoyer un message) Image The ZELIG ProjectThe program is built on evaluation, feedback, and targeted support. This support is structured around group workshops and individual follow-ups, both of which are therapeutic and psychoeducational in nature.At ZELIG, we ensure that every young person receives comprehensive and personalized support throughout their care journey.Initial information is gathered via phone or email. Following an analysis of the request, a consultation may be offered to conduct a deeper evaluation. After this preliminary meeting, a multidisciplinary team discussion is organized to determine the best course of action: either providing support at the center or referring the young person elsewhere. Evaluation scales may also be employed to enhance the assessment process.This approach is based on three key dimensions: individual, group-based, and network-focused. Individual follow-up allows for care tailored to the young person’s specific needs, while group sessions foster peer interaction and reduce isolation. Engaging key figures and external networks ensures continuity of care outside the center. Finally, psychoeducational sessions can also be offered to families and close contacts. Docteur Simone Marchini Lead Physician at ZELIGChild and Adolescent PsychiatristSpecialist in early detection and intervention for adolescents and young adultsDr. Marchini is pursuing a doctorate in science at the Faculty of Medicine, ULB. Her research focuses on developing a dimensional approach to psychiatric disorders in adolescents and young adults. Image An expert team by your side Dr. Simone Marchini: Child and Adolescent Psychiatrist, Medical DirectorDr. Edeline Clin: Child and Adolescent Psychiatrist in TrainingTwo Clinical Psychologists:Lina Regragui: Specializing in Cognitive Behavioral Therapy (CBT)Samy Adhami: Specializing in Systemic TherapyNeuropsychologist: Ella Ben-ShaoolTwo Specialized Nurses:Natalia Polozova DelaitreDéborah MorchoisneSpecialized Educator: Steven Nicaise “Peer Support” Intern: A patient partner trained for two years through the Brussels Platform for Mental HealthPrendre Rendez-vous  Early Detection of Psychiatric DisordersEarly detection of psychiatric conditions is not solely the responsibility of the ZELIG Center. It also relies on the young person's daily network: parents, relatives, teachers, sports coaches, general practitioners, and others. These key figures are often the first to notice signs of distress and alert ZELIG, enabling prompt and effective intervention.Additionally, we work closely with mental health professionals already involved in the young person’s care. This collaboration ensures continuity and consistency in the support provided.Brochure ZELIG Partner Sites of ZELIGPlateforme Bruxelloise pour la Santé mentaleBru-Stars - Réseau Bruxellois en Santé Mentale pour les Enfants et AdolescentsSimiles - association pour les familles & amis Équipes liégeoises - EcoToneLe P.A.A.T.  (Pôle Ambulatoire - Age de Transition à Liège)Equipe de VRINT à LouvainEquipe mobile âge de transition à ANVERSUZ VUB à Jette  The Prodromal Questionnaire (QP-16)The QP-16 is a screening tool designed to identify young individuals who may require a more in-depth evaluation.Recommended UseThis questionnaire is intended for frontline professionals (general practitioners, psychologists, etc.) who encounter young people displaying concerning signs. They can ask the individual to complete the QP-16.Interpreting ResultsA score of 6 or more true items serves as a strong indicator to consider referring the individual to the ZELIG program.This tool supports the early detection of prodromal signs and facilitates appropriate intervention.The goal of this screening is to enable the early identification of young people in distress and promote rapid, targeted support.Questionnaire Prodromique FAQ What criteria do you use to refer a young person to your program? ZELIG is a program designed for young people aged 12 to 21 residing in the Brussels-Capital Region who are experiencing recent psychological and functional difficulties, emerging within the last six months. The goal of ZELIG is to detect the early signs of psychiatric disorders before they escalate.These signs may include, for instance, a recent withdrawal from daily life, behavioral changes, a distorted perception of reality (feeling of strangeness), the onset of psychological distress, a breakdown in peer relationships, or disturbances in sensory perceptions—such as hearing whispers, seeing objects move, or experiencing unusual bodily sensations.In some cases, these symptoms may signal the onset of an emerging psychiatric condition, requiring timely and tailored intervention. Who can refer a young person to us? Young people can make requests themselves, as can their parents and/or close contacts. Any professional can also reach out to us, provided the young person is informed and gives their consent. How can I request an evaluation? You can send us an email at ZELIG [dot] PIJ [at] hubruxelles [dot] be.We will respond as quickly as possible to gather the initial necessary information and, if appropriate, schedule an appointment. What steps are involved in the evaluation process? To ensure a prompt response, the process begins with an initial interview involving two team members. This is followed by a medical appointment with a child and adolescent psychiatrist. Additionally, other appointments may be scheduled for administering standardized assessment tools. Medical tests might also be prescribed to rule out any underlying physical conditions.At the end of this process, a feedback session is held with the involved team members to discuss the results and propose potential courses of action. What evaluation tools do you use? Our evaluations are comprehensive. They may include physical health assessments, semi-structured interviews, and standardized scales, all aimed at enriching and refining the care process. Are the services free of charge? The fees are regulated by INAMI rates. It is necessary to have valid health insurance coverage. Is there a similar program in the Flemish and Walloon regions? Walloon region(Liège) :Équipes liégeoises - EcoToneLe P.A.A.T.  (Pôle Ambulatoire - Age de Transition à Liège)Flemish Region:Equipe de VRINT à LOUVAINEquipe mobile âge de transition à ANVERS What should I do if my child or friend isolates themselves and no longer leaves their home? You can reach out to mobile teams. The appropriate mobile team to contact will depend on the young person’s age and place of residence.For example: Bru-Stars - Réseau Bruxellois en Santé Mentale pour les Enfants et Adolescents Does your center provide support for families? Yes, we offer family support. The "BREF" module (sessions focused on family psychoeducation) is an intervention designed for the caregivers of young people supported by the ZELIG program.For additional support, you can also reach out to caregiver associations:Similes - association pour les familles & amis Plateforme Bruxelloise pour la Santé mentale The evaluation… what happens next? The feedback from the assessments provides a range of tools that can benefit both the young person and their family or close contacts. Supported follow-up through individual sessions (medical, psychological, and case management) helps prevent or even avoid future deterioration.The tools include:Establishing a care network if none exists and if it is relevant for the young person.Psychoeducational and psychotherapeutic group workshops.Support for the young person’s family/close contacts (psychoeducation).Most importantly, reactivating the young person’s network to help them build a life project focused on personal growth, self-affirmation, maintaining and creating connections, and ultimately achieving self-realization.  +32(0)2 555 80 04  ZELIG.PIJ@hubruxelles.be Erasme Medical Center (EMC) Route de Lennik 900 − 1070 Bruxelles Standard +32 (0)2 555 31 11 Image

On 27 May in Brussels, the Epikids Neuro Center of the University Hospital of Brussels (H.U.B.) will host a seminar bringing together several leading European and North American specialists. The event will provide an opportunity to review recent advances and current clinical practices in the management of rare, complex, or treatment-resistant forms of childhood epilepsy. Long confined to a strictly symptomatic approach, the management of childhood epilepsy is now undergoing significant changes, driven by advances in fundamental research, improved diagnostic methods, and the emergence of new therapeutic strategies. In Brussels, a seminar will soon bring together several European and North American specialists to review these developments and share clinical practices in the care of complex, rare or treatment-resistant forms of the condition.Professor Christian Korff, paediatric neurologist in Geneva, will open the session with a presentation on the development of new targeted molecules for monogenic and refractory epilepsies. His work, at the crossroads of clinical research and genetics, sheds light on the therapeutic potential of this still largely exploratory field.Neuropsychologist Simon Baijot will offer a complementary perspective, using clinical case studies to illustrate how neuropsychological assessment helps tailor follow-up care and anticipate cognitive vulnerabilities linked to epilepsy.Psychologist Sophie Carlier will explore the behavioural management of children with epilepsy and intellectual disabilities. She will present functional care strategies built around realistic goals and daily integration into the lives of both families and care teams.The surgical approach will be addressed through two contributions. Dr Claudine Sculier will highlight the benefits of early intervention in refractory epilepsy, emphasising both the epileptic and cognitive impact of such a strategy. Dr Sophie Schuind will present the LITT (Laser Interstitial Thermal Therapy) technique — a relatively recent option in paediatrics — which enables the precise targeting of epileptogenic lesions with a moderate risk profile.Finally, Professor Cecil Hahn, paediatric neurologist at the Hospital for Sick Children in Toronto, will discuss epileptic seizures in intensive care — often subclinical yet potentially serious if not detected early. A specialist in neuromonitoring and pioneer in continuous EEG, he will review the diagnostic tools and care strategies best suited to these critical contexts.Programme and RegistrationDate: Monday 27 May 2025Time: 08:30 – 12:00Venue: P.-P. Lambert Auditorium,Place Arthur Van Gehuchten 4, 1020 BrusselsThis morning session is intended for general practitioners, paediatricians, neurologists, child psychiatrists, healthcare providers, psychologists, non-profit organisations, journalists, and anyone concerned with current issues in children’s neurological health.📧 Contact and registration: https://www.huderf.be/fr/advancing-care-and-treatment-pediatric-epilepsy 🧠 EpiKids NeuroCenter – H.U.B. https://www.huderf.be/fr/epikids-neuro-center-hub Liens:https://www.erasme.be/fr/services/neuropediatrie-0 https://www.huderf.be/fr/services/neuropediatriehttps://ligueepilepsie.be/Seminaire-EPILEPSIE-PEDIATRIQUE.html Service de Neurochirurgie Neurochirurgie | Hôpital Erasme  

For the 2025–2026 academic year, the Université Hospital of Brussels (H.U.B.) is organising a series of seminars dedicated to rare diseases.Open to all, these events bring together leading experts, patients and their families, with the aim of raising awareness, sharing the latest research developments, and strengthening collaboration at both European and international levels. Who is it for?Healthcare professionals (all disciplines)Patients, families and relativesStudents, associations and the general publicWhy take part?Review the latest scientific and therapeutic advancesUnderstand the ethical, medical and societal challengesDiscover the role of European Reference Networks (ERNs)Exchange with specialists and patient representativesOrganisationWhen? First Tuesday of every month, 12:30–13:30World Rare Disease Day: 27 February 2026, special afternoon session (13:00–17:00)Where? Online via a web link – free participation, no registration requiredAccreditation for healthcare professionals: Ethics & Economy accreditation requested for each sessionProgramme & Speakers7 October 2025 — Béatrice GulbisRare diseases and the child-to-adult transition: what role for the ERNs?Focus on continuity of care and collaboration between specialised centres.2 December 2025 — Alec AebyRare childhood epilepsies (EPICARE network)Typologies, diagnostic challenges and innovations enabled by European cooperation.3 February 2026 — Catheline VilainRare genetic disorders (ITHACA network)Rapidly evolving diagnostic tools (genome sequencing, molecular analysis) and therapeutic perspectives.27 February 2026 — World Rare Disease Day (13:00–17:00)Vinciane Vlieghe (Neonatology): early diagnosis from birthViola Weeda (Paediatric Hepatology): rare liver diseases and new perspectivesRDB (parents’ testimony): the daily reality of familiesChristine Fonteyne (Chronic Care): hospital and home-based management, global and personalised approach7 April 2026 — Nicolas DeconinckRare neuromuscular diseases (EURO-NMD)Innovative therapies (genetic and drug-based) and multidisciplinary follow-up.2 June 2026 — Christine DevalckRare childhood cancers (PaedCan)Specificities, complex diagnoses and progress made possible through shared protocols.Practical Information & AccreditationAccès : le lien Visio est publié sur la page webAccréditation (Éthique & Économie) : une attestation par séance sera disponible.Questions & accréditation pour les soignants : maladiesrares [at] hubruxelles [dot] be (Envoyer un mail )Maladies rares | Hôpital Universitaire de Bruxelles

Under construction The Erasmus Hospital offers this service for the care of our patients. The page is currently being updated. However, you can make an appointment for this service by clicking on "make an appointment".

Our role  Digestive surgery concerns the surgical treatment of pathologies of the digestive tract, pancreas, spleen, liver, bladder and bile ducts, peritoneum and adrenal glands. Spanning the Erasmus Hospital and the Jules Bordet Institute, our Brussels University Hospital (H.U.B) interhospital department treats cancers as well as other non-cancerous pathologies affecting these organs. The minimally invasive laparoscopic or robot-assisted surgery is used as a priority depending on the surgical indications.   Image Our specialities  The Interhospital Department of Digestive Surgery consists of 4 major units within which specialist surgeons operate: The Hepato-Pancreatico-Biliary Surgery, Liver Transplant and Adrenal Clinic is concerned with surgery of the liver (liver cancers of the hepatocarcinoma or cholangiocarcinoma type, hepatic metastases, benign liver tumours), the pancreas (pancreatic cancers, duodenal cancers, neuroendocrine tumours, cystic lesions, chronic pancreatitis) and bile ducts as well as liver transplants and adrenal pathologies.  The Oesogastric, Bariatric and Abdominal Wall Clinic covers cancerous (oesophageal and stomach cancer) or functional pathologies (hiatal hernia and gastroesophagial reflux) of the upper digestive tract, obesity surgery (sleeve gastrectomy, gastric bypass,etc.) and abdominal wall surgery (hernia, eventration).The Colorectal, Peritoneal and Proctology Clinic carries out surgery for cancerous (colorectal cancer) or benign (Crohn’s disease, ulcero hemorrhagic rectoilitis) pathologies of the  colon, rectum, peritoneum (peritoneal carcinomatosis) and anus (prolapsus, haemorrhoids, anal fistula, incontinence).The Kidney Transplant and Organ Donation Functional Unit is responsible for kidney transplants and organ donations in cooperation with the transplant coordination team.    Our team Image Our specialists Colorectal Surgery ClinicPr. Gabriele LIBERALEDr. Najla BACHIRDr. Fikri BOUAZZADr. Joost MAURISSENConsultantsDr. Nicolas CLAEYSDr. Florence HUTHepato-Pancreato-Biliary Surgery ClinicPr. Ali BOHLOKPr. Vincent DONCKIERPr. Patrizia LOIDr. Desislava GERMANOVADr. Valerio LUCIDIDr. Julie NAVEZConsultantsDr. Jean CLOSSET Functional Unit for Kidney TransplantationDr. Thomas CAESDr. Nikolaos KOLIAKOSDr. Dimitri MIKHALSKIOesogastric, Bariatric and Abdominal Wall Surgery ClinicDr. Maarten VANDER KUYLENConsultantsPr. Issam EL NAKADIPr. Patrizia LOIDr. Jean CLOSSETDr. Meriem ENNAJIDr. Abdel Ilah MEHDIPediatric Surgery ClinicDr. Pierre LINGIER Focus Since July 2019 the site of the H.U.B’s Erasmus Hospital has been a reference centre approved by the INAMI/RIZIV [National Institute for Health and Disability Insurance]  for surgery of the pancreas and oesophagus. This is in keeping with the  Ministry of Health’s project to centralise complex surgery at experienced  high volume hospitals with a large multidisciplinary technical platform so as to improve the quality of care for these pathologies.   Liver transplantation is also an area in which our department excels, for the treatment of serious liver disease (acute and chronic) as well as primary liver cancer, offering excellent results in the long term. In 2023 our team carried out its 1,000th liver transplant.   The Department of Digestive Surgery has developed expertise in the treatment of peritoneal metastases. The surgery can be coupled with Intraperitoneal Hyperthermic Chemotherapy (IPHC). This technique involves administering a “bath” of anticancer drugs with the aim of destroying residual cancer cells after surgical resection of the metastases.    Research Operating within a university hospital, the development of medical knowledge through scientific research is seen as an essential role of our interhospital department. As such, we take part in a number of clinical trials and you may be asked whether you wish to participate and thereby have the opportunity to receive an innovative treatment. The Department of Digestive Surgery works with the ULB’s Laboratory of Experimental Gastroenterology on translational research, especially on pancreatic cancer and liver diseases and cancers. This enables us to better understand the mechanisms of these pathologies and improve their treatment.  Publications Lien vers Array Tumor biology reflected by histological growth pattern is more important than surgical margin for the prognosis of patients undergoing resection of colorectal liver metastases. Bohlok A, Inchiostro L, Lucidi V, Vankerckhove S, Hendlisz A, Van Laethem JL, Craciun L, Demetter P, Larsimont D, Dirix L, Vermeulen P, Donckier V. Eur J SurgOncol 2023.  14 January 2023 Lien vers Array Long-Term Outcomes 10 Years after Laparoscopic Sleeve Gastrectomy: a Single Center Retrospective Analysis. Vital R, Navez J, Gunes S, Tonneau C, Mehdi A, Moussaoui IE, Closset J. ObesSurg 2023.  14 August 2023 Lien vers Array Neoadjuvant chemotherapy associated with isotoxic high-dose stereotactic body radiotherapy does not increase postoperative complications after pancreaticoduodenectomy for nonmetastatic pancreatic cancer. Navez J, Bouchart C, Mans L, Devos S, Loi P, Closset J, Van Laethem JL. J Surg Oncol 2023 14 July 2023 Lien vers Array Esophageal cancer: Outcome and potential benefit of esophagectomy in elderly patients. Laurent A, Marechal R, Farinella E, Bouazza F, Charaf Y, Gay F, Van Laethem JL, Gonsette K, El Nakadi I. 2022 14 October 2022

Under constrcution The Erasmus Hospital offers this service for the care of our patients. The page is currently being updated. However, you can make an appointment for this service by clicking on "make an appointment". Our team Image Our specialists

Our role Established in 1979 as Belgium's first non-cardiac thoracic surgery department, the H.U.B.'s thoracic surgery department has a specific focus on improving the diagnosis and surgical treatment of thoracic pathologies affecting the lung, thymus or chest wall.  Image We offer multidisciplinary care for all thoracic oncological and non-oncological pathologies. Dr Youri Sokolow Director of the Thoracic Surgery Service at the H.U.B.  Our specialities The H.U.B. Interhospital Department of Thoracic Surgery focuses on four major activities that correspond to various types of pathology: The thoracic cancer pathology covers the multidisciplinary treatment of lung cancer and other thoracic cancers: mesotheliom       a, thymoma and pulmonary metastases.  Bridging the Jules Bordet Institute and the Erasmus Hospital, these interventions represent the greater part of the department’s activities.   The functional thoracic pathology covers in particular surgery of malformations of the thoracic wall, emphysema surgery (reduction in pulmonary volume) and surgical treatment of the pneumothorax and thoracic traumas. Lung transplants are organised within the Reference Centre for Cystic Fibrosis and Lung Transplants, jointly with the Pneumology Department. Cervical surgery covers surgery of the thyroid and trachea.  Our team Image Our medical specialists Focus The H.U.B. Interhospital Department of Thoracic Surgery was a pioneer in the field of Video-Assisted Thoracoscopic Surgery (VATS). This surgical method is less invasive and makes it possible to avoid major surgery through large openings. This reduces the risk of complications and the period of hospitalisation with a more rapid post-operative recovery. Research The H.U.B.’s thoracic surgery and pneumology teams work together on treating early stage lung cancer. The aim is to reduce the quantity of lung tissue that has to be removed. To this end they have developed a combined endoscopic and surgical approach to the treatment of small nodules. 

Our role The role of the vascular surgeon is to treat pathologies of the veins and arteries, with the exception of the heart, the proximal segment of the aorta and the brain. We devote much of our time in consultations to screening and considering cardiovascular risk factors. Our very close collaboration with Interventional Radiology and Medical Imaging provides us with rapid access to the diagnostic examinations that are essential in deciding on the best course of action for our patients, whether medical, surgical, endovascular or mixed.    Image Our specialities The Erasmus Hospital Vascular Surgery Department treats the following pathologies:     Arterial disease : Carotid surgery – Endovascular or surgical treatment of the abdominal aorta  – Arteriopathy of the lower limbs, etc. Venous diseases (phlebology), in particular symptoms of chronic venous insufficiency of the lower limbs: varicose veins, varicose ulcers, etc. Vascular acrosyndrome. Examples: Raynaud’s syndrome, chilblains, etc. Pathologies relating to coagulation disorders. Examples : thrombophilia, anticoagulation, venous thromboses (clot, pulmonary embolism). Vascular surgeons cooperate closely with their colleagues from the Diabetic Foot Clinic, the Stroke Center (Neurology) and Nephrology, principally in relation to vascular access for dialysis and kidney transplants.